BI
Last reporting period 30 Jun, 2023
Updated 18 Sep, 2024
Last price
—
Market cap $B
1.519
Exchange
XETR - Xetra
-0.038 B
Last period FCFE ,EUR
-86%
FCFE has decreased in 5 years
What is FCFE ?
Free cash flow is the amount of cash a company has after all operating expenses, interest and taxes, and capital expenditures have been paid.
See also Biotest
Company Analysis
BIO.DE valuation, rating, competitors, insights and company profile
Eyestock Rating
BIO.DE financial analysis by Eyestock methodology
Valuation
BIO.DE valuation using historical relative method
Statements
BIO.DE Income Statements, Balance Sheet and Cash Flow Statements
Dividends
BIO.DE dividend yield and annual dividend
Free cash flow is the amount of cash a company has after all operating expenses, interest and taxes, and capital expenditures have been paid.
Biotest`s FCFE for the period ended 2023-06-30 is -0.038 B EUR
